SCHEMBL20009433

SCHEMBL20009433

C=C(Nc1ccc(C)c(-c2cc(OCC3(N)CCC3)nc(N(CCC)CCC)c2)c1)c1ccnc(F)c1

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 20/20 0.37
BRAF P15056 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20009437 0.84 RAF1 (0.38) RAF1BRAF
SCHEMBL26815928 0.68 RAF1 (0.66) RAF1BRAF
SCHEMBL20009420 0.65 RAF1 (0.32) RAF1BRAF
SCHEMBL20009106 0.64 MAPT (0.35) RAF1
SCHEMBL20009442 0.64 RAF1 (0.47) RAF1BRAF
SCHEMBL20009398 0.61 RAF1 (0.49) RAF1BRAF
SCHEMBL20008439 0.58 RAF1 (0.67) RAF1BRAF
SCHEMBL20010375 0.58 RAF1 (0.52) RAF1BRAF
SCHEMBL20008454 0.56 NPC1 (0.31)
SCHEMBL23654343 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3299367-A1 BIARYL AMIDE COMPOUNDS AS KINASE INHIBITORS Novartis AG (CH) 2018-03-28 EP disclosed